EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
Notification Letter and Request Form to Non-registered Shareholders
NOTICE OF 2020 ANNUAL GENERAL MEETING
Form of Proxy for use at the 2020 Annual General Meeting to be held on Friday, May 28, 2021
2020 ANNUAL REPORT
2020 AGM CIRCULAR
NOTICE OF BOARD MEETING
VOLUNTARY ANNOUNCEMENT
VOLUNTARY ANNOUNCEMENT - ENROLLMENT OF PHASE III CLINICAL TRIAL FOR 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (CRM197, TT)
INSIDE INFORMATION RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) APPROVED FOR EMERGENCY USE IN CHILE
Monthly Return of Equity Issuer on Movements in Securities
1
35
36
37
38
39
52
津公网安备12011602300399
